Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.
2.

Presenting life with cystic fibrosis: a Q-methodological approach to developing balanced, experience-based prenatal screening information.

Wright KF, Bryant LD, Morley S, Hewison J, Duff AJ, Peckham D.

Health Expect. 2015 Oct;18(5):1349-62. doi: 10.1111/hex.12113. Epub 2013 Aug 2.

3.

trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor.

Reiter LA, Koch K, Piscopio AD, Showell HJ, Alpert R, Biggers MS, Chambers RJ, Conklyn MJ, Cooper K, Cortina SR, Dibrino JN, Dominy BW, Farrell CA, Hingorani GP, Martinelli GJ, Ramchandani M, Wright KF.

Bioorg Med Chem Lett. 1998 Jul 21;8(14):1781-6.

PMID:
9873433
4.

The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543.

Showell HJ, Conklyn MJ, Alpert R, Hingorani GP, Wright KF, Smith MA, Stam E, Salter ED, Scampoli DN, Meltzer S, Reiter LA, Koch K, Piscopio AD, Cortina SR, Lopez-Anaya A, Pettipher ER, Milici AJ, Griffiths RJ.

J Pharmacol Exp Ther. 1998 Jun;285(3):946-54.

5.

Differential in vivo and in vitro bronchorelaxant activities of CP-80,633, a selective phosphodiesterase 4 inhibitor.

Wright KF, Turner CR, Jayasinghe-Beck R, Cohen VL, Cheng JB, Watson JW.

Can J Physiol Pharmacol. 1997 Aug;75(8):1001-8.

PMID:
9360015
6.

Adjunctive cabergoline therapy of Parkinson's disease: comparison with placebo and assessment of dose responses and duration of effect.

Ahlskog JE, Wright KF, Muenter MD, Adler CH.

Clin Neuropharmacol. 1996 Jun;19(3):202-12.

PMID:
8726539
7.

Fluctuating Parkinson's disease. Treatment with the long-acting dopamine agonist cabergoline.

Ahlskog JE, Muenter MD, Maraganore DM, Matsumoto JY, Lieberman A, Wright KF, Wheeler K.

Arch Neurol. 1994 Dec;51(12):1236-41.

PMID:
7986180
9.

Discrimination of A1 versus A2 receptor subtype selectivity of adenosine receptor agonists in vivo.

Barrett RJ, Droppleman DA, Wright KF.

J Pharmacol Exp Ther. 1994 Mar;268(3):1166-73.

PMID:
8138929
10.

Multicenter study of cabergoline, a long-acting dopamine receptor agonist, in Parkinson's disease patients with fluctuating responses to levodopa/carbidopa.

Lieberman A, Imke S, Muenter M, Wheeler K, Ahlskog JE, Matsumoto JY, Maraganore DM, Wright KF, Schoenfelder J.

Neurology. 1993 Oct;43(10):1981-4.

PMID:
8105422
11.

N-0861 selectively antagonizes adenosine A1 receptors in vivo.

Barrett RJ, Droppleman DA, Wright KF.

Eur J Pharmacol. 1992 May 27;216(1):9-16.

PMID:
1526257
12.
13.

Protective effect of p-chlorophenylalanine in glycerol-induced acute renal failure in rats.

Barrett RJ, Taylor DR, Wright KF.

Clin Sci (Lond). 1989 Aug;77(2):145-7.

PMID:
2527662
14.

Effect of bopindolol on renin secretion and renal excretory function in rats.

Proakis AG, Barrett RJ, Anderson LA, Wright KF, Taylor DR.

J Cardiovasc Pharmacol. 1989 Jun;13(6):862-9.

PMID:
2484080
15.

Cardiovascular and renal actions of calcium channel blocker chemical subgroups: a search for renal specificity.

Barrett RJ, Wright KF, Taylor DR, Proakis AG.

J Pharm Pharmacol. 1988 Jun;40(6):408-14.

PMID:
2901472
16.

Involvement of dopamine receptor subtypes in dopaminergic modulation of aldosterone secretion in rats.

Barrett RJ, Wright KF, Taylor DR, Proakis AG.

Life Sci. 1987 Apr 13;40(15):1499-506.

PMID:
2951574
17.

The effect of tranylcypromine on levels of 6-keto-PGF1 alpha and other prostaglandins in brain and mesentery of the mouse.

Ellis EF, Rosenblum WI, Birkle DL, Wright KF, Traweek DL, Saady JJ, Choi SC.

Artery. 1982;10(6):454-64.

PMID:
6961890
18.
19.

Prostaglandin levels in isolated brain microvessels and in normal and norepinephrine-stimulated cat brain homogenates.

Birkle DL, Wright KF, Ellis CK, Ellis EF.

Prostaglandins. 1981 Jun;21(6):865-77.

PMID:
7291591
20.

Effect of oral aspirin dose on platelet aggregation and vascular prostacyclin (PGI2) synthesis in humans and rabbits.

Ellis EF, Wright KF, Jones PS, Richardson DW, Ellis CK.

J Cardiovasc Pharmacol. 1980 Jul-Aug;2(4):387-97.

PMID:
6156337
21.

Effect of oral aspirin dose on platelet aggregation and arterial prostacyclin synthesis: studies in humans and rabbits.

Ellis EF, Jones PS, Wright KF, Richardson DW, Ellis CK.

Adv Prostaglandin Thromboxane Res. 1980;6:313-5. No abstract available.

PMID:
6770601

Supplemental Content

Loading ...
Support Center